Current data confirm that the 6MWT , ISWT and ESWT are valid , reliable and responsive to change with some interventions .
However , results are sensitive to small changes in methodology .
Field walking tests are commonly employed to evaluate exercise capacity , assess prognosis and evaluate treatment response in chronic respiratory diseases .
In recent years , there has been a wealth of new literature pertinent to the conduct of the 6-min walk test ( 6MWT ) , and a growing evidence base describing the incremental and endurance shuttle walk tests ( ISWT and ESWT , respectively ) .
The aim of this document is to describe the st and ard operating procedures for the 6MWT , ISWT and ESWT , which can be consistently employed by clinicians and research ers .
The Incremental Shuttle Walk Test in Older Brazilian Adults
Background : Despite widespread use of the incremental shuttle walk distance ( ISWD ) , there are no reference equations for predicting it . Objectives : We aim ed to evaluate ISWD in healthy subjects and to establish a reference equation for its prediction . Methods : 131 Brazilian individuals ( 61 males ; 59 ± 10 years ) performed 2 walk tests in a 10-m long corridor . We assessed height , weight , body mass index , forced expiratory volume in 1 s , forced vital capacity and self-reported physical activity  . Results : Mean ISWD was greater in males than in females ( 606 ± 167 vs. 443 ± 117 m ; p < 0.001 ) . ISWD correlated significantly ( p < 0.05 ) with age ( r = –0.51 ) , height ( r = 0.54 ) and weight ( r = 0.20 ) . A predictive model including age , height , weight and gender explained 50.3 % of the ISWD variance . In an additional group of 20 subjects prospect ively studied , the difference between measured and predicted ISWD was not statistically significant ( 534 ± 84 vs. 552 ± 87 m , respectively ) , representing 97 ± 12 % of the predicted value calculated with our reference equation for ISWD . Conclusions : This reference equation including demographic and anthropomorphic attributes could be useful for interpreting the walking performance of patients with chronic diseases that affect exercise capacity
Current data confirm that the 6MWT , ISWT and ESWT are valid , reliable and responsive to change with some interventions .
However , results are sensitive to small changes in methodology .
Field walking tests are commonly employed to evaluate exercise capacity , assess prognosis and evaluate treatment response in chronic respiratory diseases .
In recent years , there has been a wealth of new literature pertinent to the conduct of the 6-min walk test ( 6MWT ) , and a growing evidence base describing the incremental and endurance shuttle walk tests ( ISWT and ESWT , respectively ) .
The aim of this document is to describe the st and ard operating procedures for the 6MWT , ISWT and ESWT , which can be consistently employed by clinicians and research ers .